
The pharmaceutical industry is well-poised for substantial growth and profitability in the upcoming years, backed by expanding medical needs globally, growing research and development (R&D) efforts, and rising adoption of the latest digital technologies.
Given the industry’s bright growth prospects, fundamentally sound pharma stocks AbbVie Inc. (ABBV), Collegium Pharmaceutical, Inc. (COLL), and Merck & Co., Inc. (MRK) could be ideal investments for solid returns.